Remifentanil-midazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia.

Publisher: Blackwell Country of Publication: United States NLM ID: 9010756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-8167 (Electronic) Linking ISSN: 10453873 NLM ISO Abbreviation: J Cardiovasc Electrophysiol Subsets: MEDLINE

Publication: Malden, MA : Blackwell
Original Publication: Mt. Kisco, N.Y. : Futura Pub., c1990-

Catheter Ablation/*methods ; Hemodynamics/*drug effects ; Hypnotics and Sedatives/*administration & dosage ; Midazolam/*administration & dosage ; Piperidines/*administration & dosage ; Tachycardia, Ventricular/*drug therapy; Catheter Ablation/adverse effects ; Drug Therapy, Combination ; Hemodynamics/physiology ; Humans ; Male ; Remifentanil ; Tachycardia, Ventricular/physiopathology ; Tachycardia, Ventricular/surgery ; Treatment Outcome ; Young Adult

Epicardial ablation of ventricular tachycardia (VT) presents multiple challenges for anesthetic management. General anesthesia lowers blood pressure, may interfere with arrhythmia mapping, and use of muscle relaxants precludes identification of the phrenic nerve. We describe a case in which remifentanil with minimal doses of midazolam was employed in a series of epicardial VT ablations and noninvasive programmed stimulations (NIPS), including 5 external cardioversions and discuss the advantages of this approach.
(© 2010 Wiley Periodicals, Inc.)

0 (Hypnotics and Sedatives)
0 (Piperidines)
P10582JYYK (Remifentanil)
R60L0SM5BC (Midazolam)

Date Created: 20100904 Date Completed: 20120306 Latest Revision: 20181201

20221213

10.1111/j.1540-8167.2010.01889.x

20812933